Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B.
about
Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy.IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection.Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota.Chronic hepatitis B surface antigen seroclearance-related immune factors.Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans.Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.
P2860
Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genetic variation in STAT4 pre ...... -positive chronic hepatitis B.
@en
type
label
Genetic variation in STAT4 pre ...... -positive chronic hepatitis B.
@en
prefLabel
Genetic variation in STAT4 pre ...... -positive chronic hepatitis B.
@en
P2093
P2860
P356
P1433
P1476
Genetic variation in STAT4 pre ...... -positive chronic hepatitis B.
@en
P2093
Carly Conran
De-Ke Jiang
Jingmin Yang
Kangmei Chen
P2860
P304
P356
10.1002/HEP.28423
P407
P50
P577
2015-12-24T00:00:00Z